Taiwan FDA registration 883b4d6833d9bd78b18867e316a61713
Waters High Pressure Liquid Phase Analysis Instrument for Clinical Use (Unindefatted)
TW: 沃特斯 臨床使用的高壓液相層析儀 (未滅菌)
Taiwan·Risk Class 1·GES Singapore Pte Ltd.;; WATERS CORPORATION·Registered Nov 28, 2024 – Oct 31, 2026ActiveRegistration details
- Analysis ID
- 883b4d6833d9bd78b18867e316a61713
- Customs Code
- DHA084A0032601
Company information
- Manufacturer
- GES Singapore Pte Ltd.;; WATERS CORPORATION
- Manufacturer Country
- United States;;Singapore
- Authorized Representative
- EMERGO TAIWAN LIMITED
Product details
- Intended Use
- It is limited to the first level of identification of the classification and grading management of medical devices "high-pressure liquid chromatography instrument for clinical use (A.2260)".
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.2260 High-pressure liquid chromatography for clinical use
- Import Information
- Input;; Contract manufacturing
Dates and status
- Registration Date
- Nov 28, 2024
- Expiry Date
- Oct 31, 2026
About this record
Access comprehensive regulatory information for Waters High Pressure Liquid Phase Analysis Instrument for Clinical Use (Unindefatted) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 883b4d6833d9bd78b18867e316a61713 and manufactured by GES Singapore Pte Ltd.;; WATERS CORPORATION. The authorized representative in Taiwan is EMERGO TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices